Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: A phase II Hoosier Oncology Group (HOG 97-01) study

Gynecologic Oncology

Volumn 96, Issue 3, 2005, Pages 818-823

  Fakiris, Achilles J ^a   Moore, David H ^a   Reddy, Shailaja R ^a   Look, Katherine Y ^a   Yiannoutsos, Constantin T ^a   Randall, Marcus E ^a   Cardenes, Higinia R ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORUS 32;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; SCAR; SURGICAL TECHNIQUE; UTERUS CARCINOMA;

EID: 13844280283     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.11.050     Document Type: Article

References (39)

1. L.A.G. Ries M.P. Eisner C.L. Kosary SEER Cancer Statistics Review, 1975-2000 2004 National Cancer Institute Bethesda, MD
2. M. Hendrickson, J. Ross, P. Eifel, A. Martinez, and R. Kempson Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma American Journal of Surgical Pathology 6 2 1982 93 108
3. F.D. Cirisanov Jr., S.J. Robboy, and R.K. Dodge The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma Gynecol. Oncol. 77 1 2000 55 65
4. B.M. Sood, J. Jones, and S. Gupta Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma Int. J. Radiat. Oncol. Biol. Phys. 57 1 2003 208 216
5. P.A. Gehrig, P.A. Groben, and W.C. Fowler Jr. Noninvasive papillary serous carcinoma of the endometrium Obstetrics and Gynecology 97 1 2001 153 157
6. B.G. Ward, R.G. Wright, and K. Free Papillary carcinomas of the endometrium Gynecol. Oncol. 39 1990 347 351
7. G.P. Sutton, L. Brill, H. Michael, F.B. Stehman, and C.E. Ehrlich Malignant papillary lesions of the endometrium Gynecol. Oncol. 27 1987 294 304
8. B.M. Slomovitz, T.W. Burke, and P.J. Eifel Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases Gynecol. Oncol. 91 3 2003 (Dec.) 463 469
9. J.P. Geisler, H.E. Geisler, M.E. Melton, and M.C. Wiemann What staging surgery should be performed on patients with uterine papillary serous carcinoma Gynecol. Oncol. 74 3 1999 (Sep.) 465 467
10. B.A. Goff, D. Kato, and R.A. Schmidt Uterine papillary serous carcinoma: patterns of metastatic spread Gynecol. Oncol. 54 1994 264 268
11. R.E. Bristow, F. Asrari, and E.L. Trimble Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease Gynecol. Oncol. 81 2 2000 279 286
12. G. Gitsch, M.L. Friedlander, G. Wain, and N.F. Hacker Uterine papillary serous carcinoma. A clinical study Cancer 75 1995 2239 2243
13. E.H. Tay, and B.G. Ward The treatment of uterine papillary serous carcinoma (UPSC): are we doing the right thing Int. J. Gynecol. Cancer 9 1999 463 469
14. W.K. Huh, M. Powell, and C.A. Leath Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy Gynecol. Oncol. 91 3 2003 (Dec.) 470 475
15. D. Bancher-Todesca, W. Neunteufel, and K.E. Williams Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma Gynecol. Oncol. 71 3 1998 (Dec.) 344 347
16. P.S. Craighead, K. Sait, and G.C. Stuart Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994 Gynecol. Oncol. 77 2 2000 (May) 248 253
17. J. Axelrod, J. Bundy, and T. Roy Advanced endometrial carcinoma (EC) treated with whole abdominal irradiation (WAI): a Gynecologic Oncology Group (GOG) study (abstract) Gynecol. Oncol. 56 1995 135 136
18. W.T. Creasman, P.J. Di Saia, and J.A. Blessing Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals Am. J. Obstet. Gynecol. 141 1981 941
19. 32P) in women with early ovarian carcinoma after comprehensive surgical staging Obstet. Gynecol. 79 1992 993 997
20. R.C. Young, L.A. Walton, and S.S. Ellenberg Adjuvant therapy in stage I and stage II epithelial ovarian cancer: Results of two randomized trials N. Engl. J. Med. 322 1990 1021 1027
21. 32P following second-look laparotomy for ovarian cancer Int. J. Radiat. Oncol. Biol. Phys. 9 1983 98 [abstract]
22. J.T. Soper, W.T. Creasman, and D.L. Clarke-Pearson Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma Am. J. Obstet. Gynecol. 153 1985 191 196
23. S.A. Leibel T.L. Phillips Textbook of radiation oncology 1998 Philadelphia Pa: Saunders
24. J.A. Roberts, V.L. Brunetto, and H.M. Keys A phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma (GOG99) Proc. Soc. Gynecol. Oncol. 29 1998 70
25. C.L. Creutzberg, W.L. van Putten, and P.C. Koper Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial carcinoma: Multicenter randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Cancer Lancet 355 2000 1404 1406
26. T.C. McCormick, H. Cardenes, and M.E. Randall Early-stage endometrial cancer: is intravaginal radiation therapy alone sufficient therapy Brachytherapy 1 2 2002 61 65
27. J.H. Shepherd Revised FIGO staging for gynaecological cancer Br. J. Obstet. Gynecol. 96 8 1989 889 892
28. S. Nag, B. Erickson, and S. Parikh The American Brachytherapy Society Recommendations for High-Dose Rate Brachytherapy for Carcinoma of the Endometrium Int. J. Radiat. Oncol. Biol. Phys. 48 3 2000 779 790
29. P. Lim, A. Al Kushi, and B. Gilks Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome Cancer 91 4 2001 (Feb 15) 752 757
30. P. Mallipeddi, D.S. Kapp, and N.H. Teng Long-term survival with adjuvant whole abdominal irradiation for uterine papillary serous carcinoma Cancer 71 1993 3076 3081
31. S. Gibbons, A. Martinez, and M. Schray Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma Int. J. Radiat. Oncol. Biol. Phys. 21 1991 1019 1025
32. A.H. Frank, P.C. Tseng, and B.G. Haffty Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma Cancer 68 1991 1516 1519
33. J. Grice, M. Ek, and B. Greer Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients Gynecol. Oncol. 69 1998 69 73
34. N. Mehta, S.D. Yamada, J. Rotmensch, and A. Mundt Outcome and Pattern of Failure in Pathologic Stage I-II Papillary Serous Carcinoma of the Endometrium: implications for Adjuvant Radiation Therapy Int. J. Radiat. Oncol. Biol. Phys. 57 4 2003 1004 1009
35. M.E. Randall, G. Brunetto, and R. Muss Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: a randomized phase III trial of the Gynecologic Oncology Group J. Clin. Oncol. 21 Suppl 1 Dec 2003 237s
36. J.F. Jeffrey, G.V. Krepart, and R.J. Loctoki Papillary serous adenocarcinoma of the endometrium Obstet. Gynecol. 67 1986 670 674
37. G.P. Sutton, L. Brill, H. Michael, F.B. Stehman, and C.E. Ehrlich Malignant papillary lesions of the endometrium Gynecol. Oncol. 27 1987 294 304
38. J.L. Nicklin, and L.J. Copeland Endometrial papillary serous carcinoma: patterns of spread and treatment Clin. Obstet. Gynecol. 39 1996 686 695
39. D.T. Kato, J.A. Ferry, and A. Goodman Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases Gynecol. Oncol. 59 1995 384 389